These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1282951)

  • 1. The inducible nitric oxide synthase is impaired by thrombin in vascular smooth muscle cells.
    Schini VB; Catovsky S; Scott-Burden T; Vanhoutte PM
    J Cardiovasc Pharmacol; 1992; 20 Suppl 12():S142-4. PubMed ID: 1282951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombin inhibits induction of nitric oxide synthase in vascular smooth muscle cells.
    Schini VB; Catovsky S; Durante W; Scott-Burden T; Schafer AI; Vanhoutte PM
    Am J Physiol; 1993 Feb; 264(2 Pt 2):H611-6. PubMed ID: 7680540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-like growth factor I inhibits induction of nitric oxide synthase in vascular smooth muscle cells.
    Schini VB; Catovsky S; Schray-Utz B; Busse R; Vanhoutte PM
    Circ Res; 1994 Jan; 74(1):24-32. PubMed ID: 7505207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of interleukin-1-alpha-induced nitric oxide synthase in vascular smooth muscle and full reversal of interleukin-1-alpha-induced hypotension by N omega-amino-L-arginine.
    Kilbourn RG; Gross SS; Lodato RF; Adams J; Levi R; Miller LL; Lachman LB; Griffith OW
    J Natl Cancer Inst; 1992 Jul; 84(13):1008-16. PubMed ID: 1376778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombin prevents the expression of inducible nitric oxide synthase in vascular smooth muscle cells by a proteolytically-activated thrombin receptor.
    Schini-Kerth VB; Fisslthaler B; Andersen TT; Fenton JW; Vanhoutte PM; Busse R
    Thromb Haemost; 1995 Sep; 74(3):980-6. PubMed ID: 8571333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitric oxide synthase inhibitors inhibit interleukin-1 beta-induced depression of vascular smooth muscle.
    French JF; Lambert LE; Dage RC
    J Pharmacol Exp Ther; 1991 Oct; 259(1):260-4. PubMed ID: 1717680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitors of calmodulin impair the constitutive but not the inducible nitric oxide synthase activity in the rat aorta.
    Schini VB; Vanhoutte PM
    J Pharmacol Exp Ther; 1992 May; 261(2):553-9. PubMed ID: 1374468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of nitric oxide synthase gene by interleukin in vascular smooth muscle cells.
    Kanno K; Hirata Y; Imai T; Marumo F
    Hypertension; 1993 Jul; 22(1):34-9. PubMed ID: 7686532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The induction of nitric oxide synthase activity is inhibited by TGF-beta 1, PDGFAB and PDGFBB in vascular smooth muscle cells.
    Schini VB; Durante W; Elizondo E; Scott-Burden T; Junquero DC; Schafer AI; Vanhoutte PM
    Eur J Pharmacol; 1992 Jun; 216(3):379-83. PubMed ID: 1385162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eicosapentaenoic acid potentiates the production of nitric oxide evoked by interleukin-1 beta in cultured vascular smooth muscle cells.
    Schini VB; Durante W; Catovsky S; Vanhoutte PM
    J Vasc Res; 1993; 30(4):209-17. PubMed ID: 8357951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of cytokine-induced nitric oxide production by transforming growth factor-beta 1 in human smooth muscle cells.
    Junquero DC; Scott-Burden T; Schini VB; Vanhoutte PM
    J Physiol; 1992 Aug; 454():451-65. PubMed ID: 1282159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoteichoic acid: a new inducer of nitric oxide synthase.
    Lonchampt MO; Auguet M; Delaflotte S; Goulin-Schulz J; Chabrier PE; Braquet P
    J Cardiovasc Pharmacol; 1992; 20 Suppl 12():S145-7. PubMed ID: 1282952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of interleukin-1-beta-stimulated inducible nitric oxide synthase expression in cultured vascular smooth muscle cells by hemostatic proteins.
    Durante W; Kroll MH; Orloff GJ; Cunningham JM; Scott-Burden T; Vanhoutte PM; Schafer AI
    Biochem Pharmacol; 1996 Mar; 51(6):847-53. PubMed ID: 8602881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of nitric oxide synthase by lipoteichoic acid from Staphylococcus aureus in vascular smooth muscle cells.
    Auguet M; Lonchampt MO; Delaflotte S; Goulin-Schulz J; Chabrier PE; Braquet P
    FEBS Lett; 1992 Feb; 297(1-2):183-5. PubMed ID: 1372565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosporin A inhibits nitric oxide synthase induction in vascular smooth muscle cells.
    Marumo T; Nakaki T; Hishikawa K; Suzuki H; Kato R; Saruta T
    Hypertension; 1995 Apr; 25(4 Pt 2):764-8. PubMed ID: 7536714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular actions of thrombin receptor-derived polypeptides: structure-activity profiles for contractile and relaxant effects in rat aorta.
    Laniyonu AA; Hollenberg MD
    Br J Pharmacol; 1995 Apr; 114(8):1680-6. PubMed ID: 7541284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aminoguanidine selectively inhibits inducible nitric oxide synthase.
    Griffiths MJ; Messent M; MacAllister RJ; Evans TW
    Br J Pharmacol; 1993 Nov; 110(3):963-8. PubMed ID: 7507781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natriuretic peptide-augmented induction of nitric oxide synthase through cyclic guanosine 3',5'-monophosphate elevation in vascular smooth muscle cells.
    Marumo T; Nakaki T; Hishikawa K; Hirahashi J; Suzuki H; Kato R; Saruta T
    Endocrinology; 1995 May; 136(5):2135-42. PubMed ID: 7536663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of nitric oxide synthase by endotoxin in rat isolated aorta but not in rat aortic smooth muscle cells grown in culture from explant.
    McKendrick JD; Paisley K; Eason S; Mian KB; Martin W
    Arch Int Pharmacodyn Ther; 1995; 330(2):206-24. PubMed ID: 8861713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyrrolidine dithiocarbamate selectively prevents the expression of the inducible nitric oxide synthase in the rat aorta.
    Schini-Kerth V; Bara A; Mülsch A; Busse R
    Eur J Pharmacol; 1994 Nov; 265(1-2):83-7. PubMed ID: 7533726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.